Mycidac-C Injection is an immunomodulator composed of heat-killed Mycobacterium W (Mw), indicated to treat NSCLC (Non-small Cell Lung Cancer) along with other anticancer agents leading to improvement in overall response, Quality of Life and survival of patients.
A gene called Desmocollin-3 (DSC-3) is expressed in the cancer cells of the lung, bladder, head & neck and prostate. Mycidac C Injection is the first immunotherapy agent that targets and manages the tumors expressed by the DSC-3 gene.
Uses of Mycidac C Injection:
Mycidac C Injection is used in the management of the following conditions:
- Non-small cell lung cancer
- Bladder cancer
- Melanoma
- Head and neck cancer
- Prostate cancer
- Optic nerve toxicity
